Toxoplasma gondii: genetic recombination between drug resistant mutants

Mutants resistant to adenine arabinoside (ara-A) or to 5-fluorodeoxyuridine (FUDR) were isolated from a newly isolated oocyst producing strain of Toxoplasma gondii. The selection and characterization of these mutants were carried out in human fibroblast cultures. The ara-A-resistant mutant lacked the enzyme adenosine kinase. The biochemical basis of FUDR resistance remains unknown. Both mutants were used to infect mice to produce brain cysts that contained bradyzoites. Mouse brains that contained cysts were fed to kittens to complete the sexual cycle of T. gondii. Those kittens fed cysts of only one drug-resistant mutant excreted oocysts that yielded no detectable recombinant doubly resistant parasites that could make plaques in the presence of both ara-A and FUDR. Kittens fed a mixture of cysts that contained both mutants excreted oocysts that contained approximately 12% doubly resistant parasites. The reciprocal recombinant, sensitive to both drugs, was also isolated. The doubly resistant recombinant was totally deficient in adenosine kinase activity. This pattern of inheritance is consistant only with a haploid genome for all stages of T. gondii except the zygote formed by fusion of gametes and the unsporulated oocyst. Two FUDR-resistant mutants were also defective in the production of oocysts. These mutants failed to recombine with an ara-A-resistant mutant of proven fertility and thus their inability to make oocysts must result from a defect in the production of both microgametes and macrogametes.